Skip to Main Content
Skip Nav Destination

Antibodies and bispecifics for multiple myeloma: effective effector therapy

Hematology Am Soc Hematol Educ Program (2022) 2022 (1): 163–172.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal